| 2004 |
TRB3 (TRIB3) directly binds to Akt and inhibits its phosphorylation/activation, functioning as an endogenous inhibitor of Akt in insulin signaling. |
Co-immunoprecipitation, overexpression and knockdown in cultured cells, adenoviral overexpression in mice |
Molecular and cellular biology (inferred from corpus context); directly demonstrated in multiple papers including PMID:16966378 |
High |
16129579 16887816 16966378 18497449 18818302
|
| 2005 |
TRIB3 gene transcription is induced by endoplasmic reticulum stress and amino acid limitation through ATF4 binding to a C/EBP-ATF composite element (AARE) in the TRIB3 promoter; TRIB3 then acts as a negative feedback regulator of ATF4 transcriptional activity. |
Promoter mapping, transcriptional start site mapping, transient transfection, chromatin immunoprecipitation, siRNA knockdown |
Biochemical and biophysical research communications; PloS one |
High |
15781252 21203563
|
| 2007 |
TRIB3 interacts with ATF4 and suppresses ATF4 transcriptional activity, protecting cells from ATF4-induced growth inhibition and cytotoxicity including reduction of reactive oxygen species caused by ATF4 overexpression. |
Overexpression and siRNA knockdown in HEK293, PC12, and SaOS2 cells; ROS measurement; cell viability assays |
Experimental cell research |
Medium |
17707795
|
| 2006 |
TRB3 overexpression completely inhibits insulin-stimulated p70 S6 kinase (S6K1) activation via mTOR, while knockdown of endogenous TRB3 increases basal and insulin-stimulated S6K1 activity, placing TRB3 upstream of mTOR-S6K1 signaling. |
Overexpression and knockdown in cultured cells; adenoviral overexpression in C57BL/6 mice; Western blot for S6K1 phosphorylation |
The Journal of biological chemistry |
Medium |
16887816
|
| 2011 |
TRIB3 physically interacts with SMAD3 via its kinase-like domain, promotes nuclear localization of SMAD3 by interacting with the MH2 domain, enhances SMAD3 transcriptional activity, and triggers degradation of Smurf2 (thereby reducing SMAD2/phospho-SMAD3 degradation), promoting tumor cell migration and invasion. |
Co-immunoprecipitation, domain mapping, overexpression and knockdown, nuclear fractionation, transcriptional reporter assays, migration/invasion assays |
Journal of cell science |
High |
21896644
|
| 2008 |
SIAH1 (E3 ubiquitin ligase) interacts with TRB3 both in vitro and in vivo and targets TRB3 for proteasome-dependent degradation, thereby providing a mechanism for regulation of TRB3 protein levels and its modulation of TGF-β signaling. |
Yeast two-hybrid screen, co-immunoprecipitation, in vitro binding assay, proteasome inhibitor experiments, cotransfection reporter assays |
Cellular signalling |
Medium |
18276110
|
| 2015 |
TRIB3 physically interacts with the autophagic receptor SQSTM1/p62 and hinders p62 binding to LC3 and to ubiquitinated substrates, causing p62 accumulation and suppressing autophagic and proteasomal degradation; this links insulin/IGF signaling to tumor promotion. |
Co-immunoprecipitation, pulldown assays, autophagic flux assays (LC3 lipidation, p62 accumulation), peptide competition, mouse tumor models with KD |
Nature communications |
High |
26268733 26301314
|
| 2016 |
TRB3 serves as a scaffold for the deubiquitinase USP9x; USP9x deubiquitinates and stabilizes TRB3 and also deubiquitinates Mind Bomb 1 to activate JAG1-mediated Notch signaling in response to cellular stress (nutrient deprivation or ER stress). |
Co-immunoprecipitation, deubiquitination assays, siRNA knockdown, cell-pair Notch signaling assay |
Oncogene |
Medium |
27593927
|
| 2017 |
TRIB3 interacts with PML-RARα oncoprotein, suppresses its sumoylation, ubiquitylation, and proteasomal degradation, thereby repressing PML nuclear body assembly, p53-mediated senescence, and myeloid differentiation to promote APL progression. |
Co-immunoprecipitation, ubiquitylation/sumoylation assays, genetic KD in APL cells and mouse models, peptide disruption of TRIB3/PML-RARα interaction |
Cancer cell |
High |
28486108
|
| 2019 |
TRIB3 interacts with AKT to interfere with the FOXO1-AKT interaction, suppressing FOXO1 phosphorylation, ubiquitination, and degradation by E3 ligases SKP2 and NEDD4L; accumulated FOXO1 then promotes SOX2 transcription forming a positive regulatory loop that supports breast cancer stemness. |
Co-immunoprecipitation, ubiquitination assays, overexpression and knockdown, mouse models of breast cancer, peptide disruption of TRIB3-AKT interaction |
Nature communications |
High |
31844113
|
| 2019 |
TRIB3 interacts with SQSTM1/p62 and hinders its binding to MAP1LC3/LC3, causing accumulation of SQSTM1 aggregates, obstructing autophagic flux, promoting late endosome accumulation, and enhancing hepatocellular secretion of INHBA/Activin A-enriched exosomes that activate hepatic stellate cells to drive liver fibrosis. |
Co-immunoprecipitation, autophagy flux assays, exosome isolation, helical peptide disruption of TRIB3-SQSTM1 interaction, mouse fibrosis models (BDL, TAA), human fibrotic liver samples |
Autophagy |
High |
31286822
|
| 2020 |
TRIB3 interacts with EGFR and recruits PKCα to induce Thr654 phosphorylation and WWP1-induced Lys689 ubiquitination in the EGFR juxtamembrane region, which enhances EGFR recycling, stability, downstream activity, and NSCLC stemness. |
Co-immunoprecipitation, phosphorylation/ubiquitination assays, domain mapping, stapled peptide disruption of TRIB3-EGFR interaction, mouse NSCLC models |
Nature communications |
High |
32694521
|
| 2022 |
TRIB3 is acetylated by acetyltransferase P300, which inhibits ubiquitination and subsequent proteasomal degradation of TRIB3; stabilized TRIB3 inhibits STAT1 activation and STAT1-mediated CXCL10 transcription by enhancing EGFR signaling, reducing CD8+ T cell infiltration in colorectal cancer. |
Acetylation assays, P300 inhibitor, co-immunoprecipitation, STAT1 phosphorylation assays, mouse CRC models, genetic ablation of Trib3 |
Science translational medicine |
High |
34985967
|
| 2006 |
TRB3 interacts with CtIP (CtBP-interacting protein) via the C-terminus of both proteins and co-localizes with CtIP to the nucleus in a dot-like pattern in HeLa cells. |
Co-immunoprecipitation, domain mapping, co-localization by immunofluorescence |
Biochimica et biophysica acta |
Low |
17112672
|
| 2015 |
Trib3 physically interacts with Parkin; elevated Trib3 reduces Parkin expression in cultured cells and dopaminergic neurons; Parkin knockdown abolishes the protective effect of Trib3 downregulation, placing Trib3 upstream of Parkin in PD-related neuronal death. |
Co-immunoprecipitation, overexpression and knockdown in neuronal PC12 cells and ventral midbrain dopaminergic neurons, 6-OHDA/MPP+/αSYN models, immunostaining of PD patient brains |
The Journal of neuroscience |
Medium |
26224857
|
| 2008 |
TRB3 recruits COP1 (E3 ubiquitin ligase) to SIRT1, promoting COP1-mediated K48-linked ubiquitination and proteasomal degradation of SIRT1 under lipotoxic conditions, contributing to insulin resistance in hepatocytes. |
Co-immunoprecipitation, ubiquitination assay, high-fat diet mouse model, palmitate-treated HepG2 cells, Western blot |
Experimental cell research |
Medium |
31125554
|
| 2018 |
TRIB3 acts as an adaptor to recruit KAT5 (lysine acetyltransferase 5) to SMAD3, inducing phosphorylation-dependent K333 acetylation of SMAD3 that sustains SMAD3 transcriptional activity and subsequent TRIB3 transcription, forming a positive feedback loop; metformin disrupts this loop by inhibiting SMAD3 phosphorylation. |
Co-immunoprecipitation, acetyltransferase assay, site-directed mutagenesis (K333R), reporter assays, mouse melanoma models |
Oncogene |
High |
29520103 29929422
|
| 2012 |
Caspase-3 cleaves TRB3 during apoptosis; cleavage of TRB3 promotes caspase-3/7 activation. Under non-cleaved conditions, TRB3 promotes nuclear translocation of procaspase-3, preventing cytoplasmic CASP3 activation and inhibiting apoptosis, functioning as a molecular switch between cell survival and death. |
In vitro caspase cleavage assay, overexpression of cleavable and non-cleavable TRB3 mutants, caspase activity assays, nuclear fractionation, forced cytoplasmic/nuclear expression constructs |
PloS one |
Medium |
22912727
|
| 2021 |
TRIB3 interacts with GSK-3β and stabilizes it from ubiquitination and degradation; elevated GSK-3β phosphorylates A20 to inhibit its ubiquitin-editing activity, causing accumulation of C/EBPβ and profibrotic factor production in alveolar macrophages; activated C/EBPβ increases TRIB3 and GSK-3β transcription, forming a positive feedback loop promoting pulmonary fibrosis. |
Co-immunoprecipitation, ubiquitination assays, pharmacological disruption of TRIB3-GSK-3β interaction, mouse pulmonary fibrosis models, knockdown experiments |
Acta pharmaceutica sinica B |
Medium |
34729304
|
| 2024 |
TRIB3 directly interacts with HNF4α and recruits TRIM8 to form an E3 ligase complex that catalyzes K48-linked polyubiquitination of HNF4α at lysine 470, leading to its proteasomal degradation during ER stress and NAFLD progression; the gain-of-function TRIB3 variant p.Q84R exacerbates this. |
Co-immunoprecipitation, mass spectrometry, in vivo and in vitro ubiquitination assays, molecular docking, cell-penetrating peptide disruption, mouse diet-induced NAFLD model, RNA-sequencing |
Journal of hepatology |
High |
38237865
|
| 2019 |
TRIB3 interacts with TWIST1 via the WR domain of TWIST1 and inhibits TWIST1 ubiquitination, thereby stabilizing TWIST1 protein and contributing to ATRA resistance and APL cell survival. |
Co-immunoprecipitation, ubiquitination assays, domain mapping, synthetic peptide disruption of TRIB3/TWIST1 interaction, gain/loss-of-function assays |
Clinical cancer research |
Medium |
31235507
|
| 2020 |
TRIB3 interacts with TAZ and impedes β-TrCP-mediated TAZ ubiquitination and degradation, thereby stabilizing TAZ and conferring radiotherapy resistance in esophageal squamous cell carcinoma. |
Co-immunoprecipitation, ubiquitination assays, overexpression and knockdown, in vitro and in vivo radioresistance assays |
Oncogene |
Medium |
32157210
|
| 2021 |
TRIB3 directly interacts with ERK, JNK, and p38 MAPK (demonstrated by Co-IP), and promotes proliferation and migration of hypoxic pulmonary artery smooth muscle cells via activation of these MAPK pathways; TRB3 knockdown reduces right ventricular systolic pressure and pulmonary medial wall thickness in a rat hypoxic PH model. |
Co-immunoprecipitation, specific MAPK inhibitors, lentiviral overexpression and knockdown, in vivo rat hypoxic PH model |
Respiratory research |
Medium |
34906150
|
| 2020 |
TRIB3 interacts with p62 and MAPKKs (MEK1/MEK2, MEK3/MEK6, MEK4/MKK4) in aged skeletal muscle; TRIB3 knockout reduces p62 and LC3 accumulation, decreases JNK phosphorylation, increases p38 phosphorylation, and attenuates muscle fiber atrophy and fibrosis in aged mice. |
Co-immunoprecipitation, TRB3 knockout mouse model, Western blot, electrophysiology, histopathology |
Journal of cachexia, sarcopenia and muscle |
Medium |
32096609
|
| 2014 |
TRIB3 mediates ER stress-induced β-cell apoptosis via activation of the NF-κB pathway; overexpression of TRIB3 enhances NF-κB activation and apoptosis, while TRIB3 knockdown blocks thapsigargin-induced apoptosis in INS-1 cells and in a sub-renal capsule transplantation model. |
Tet-on inducible TRIB3 overexpression, siRNA knockdown, NF-κB pathway inhibitor, TUNEL staining, sub-renal capsule transplantation in vivo |
Metabolism: clinical and experimental |
Medium |
24746137
|
| 2020 |
TRIB3 interacts with PPARγ and RXR, interfering with the PPARγ/RXR dimer interaction and promoting PPARγ degradation, thereby reducing PPARγ transcriptional activity and causing lipid metabolism disorder; this mechanism operates in both PML-RARα/APL context and after ATRA/arsenic therapy. |
Co-immunoprecipitation, dual luciferase reporter assay, Western blot, transgenic and transplanted mouse models |
Theranostics |
Medium |
32929351
|
| 2014 |
Overexpression of TRB3 in skeletal muscle shifts muscle fiber type toward more oxidative/fatigue-resistant type I/IIA fibers via a PPARα-regulated miR499/miR208b pathway, improving exercise capacity without affecting glucose uptake. |
Muscle-specific transgenic mouse model, fiber type staining, microRNA quantification (miR208b, miR499), PPARα and myosin heavy chain expression analysis, exercise capacity testing |
American journal of physiology. Regulatory, integrative and comparative physiology |
Medium |
24740654
|
| 2024 |
TRIB3 interacts with PLIN2 and abrogates TEB4-mediated PLIN2 ubiquitination and degradation, maintaining higher PLIN2 expression and facilitating lipid droplet accumulation while preserving ER homeostasis in renal cell carcinoma. |
Co-immunoprecipitation, ubiquitination assays, knockdown, bioinformatics screening, patient tissue analysis |
Cell death & disease |
Medium |
38561354
|
| 2024 |
TRIB3 interacts with TCF4 and β-catenin to form a heterotrimeric complex that directly interacts with the ALOXE3 promoter and suppresses its activation, partially neutralizing ferroptosis in head and neck squamous cell carcinoma. |
Co-immunoprecipitation, chromatin immunoprecipitation, promoter reporter assays, ALOXE3 knockdown rescue experiments, siRNA knockdown of TRIB3 |
Cell death & disease |
Medium |
38429254
|
| 2010 |
CHOP (C/EBP homologous protein) is a transcription factor that directly binds to the proximal TRIB3 promoter and activates its expression in response to oxidative stress and free fatty acids in podocytes; elevated TRIB3 in turn inhibits MCP-1/CCL2 production. |
Chromatin immunoprecipitation, CHOP transfection, TRIB3 promoter-reporter assays, siRNA knockdown |
American journal of physiology. Renal physiology |
Medium |
20660016
|
| 2010 |
Amino acid limitation activates the GCN2/eIF2α/ATF4 pathway in mouse liver, leading to ATF4, ATF2, and C/EBPβ binding to a functional Amino Acid Response Element (AARE) in the TRB3 promoter; ATF4 binding is essential for amino acid-regulated TRB3 transcription in vivo. |
Transient transfection in hepatoma cells, chromatin immunoprecipitation, leucine-deficient diet mouse model, GCN2 knockout mice |
PloS one |
High |
21203563
|
| 2020 |
TRIB3 interacts with β-catenin physically, activating β-catenin signaling to confer glioma cell stemness; β-catenin knockdown rescues the stemness enhancement caused by TRIB3 overexpression. |
Co-immunoprecipitation, overexpression and knockdown, sphere-forming assay, ALDH1 activity, rescue experiment |
Environmental toxicology |
Low |
31995275
|
| 2022 |
TRIB3 interacts with ATF4 in lung fibroblasts; TRIB3 overexpression inhibits ATF4 promoter-driven transcription activity and downregulates ATF4 expression, attenuating fibroblast activation and ECM synthesis in IPF. |
Co-culture system, overexpression and knockdown, promoter reporter assay, Western blot |
International journal of molecular sciences |
Low |
36555349
|
| 2015 |
TRIB3 knockdown in cardiomyocytes and the stretch-induced TRB3 induction is mediated through the TNF-α/JNK/GADD153 pathway; JNK inhibitor, TNF-α antibody, and TRB3 siRNA all inhibit stretch-induced cardiomyocyte apoptosis. |
Cyclic stretch model, JNK inhibitor (SP600125), TNF-α antibody, JNK siRNA, TRB3 siRNA, EMSA for GADD153 binding, TRB3 promoter reporter assay, in vivo AV shunt rat model |
PloS one |
Medium |
25898323
|
| 2019 |
TRIB3 upregulation by the drug ABTL0812 inhibits the PI3K/AKT/mTOR axis and induces autophagy-mediated cell death in endometrial cancer cells; TRIB3 mRNA was validated as a pharmacodynamic biomarker in a Phase 1b/2a clinical trial. |
siRNA knockdown, cell viability assays, Western blot for pathway components, inducible PTEN KO murine model, patient-derived xenografts, clinical trial samples |
Gynecologic oncology |
Medium |
30853360
|